DDW: Systematic Program Increases Likelihood of Up-to-Date Colorectal Cancer Screening

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on April 25, 2025.

By Elana Gotkine HealthDay Reporter

FRIDAY, April 25, 2025 -- A systematic program of monitoring colorectal cancer (CRC) screening status increases up-to-date screening status, according to a study presented at the 2025 Digestive Disease Week, held from May 3 to 6 in San Diego.

Douglas Corley, M.D., Ph.D., from Kaiser Permanente Northern California in Pleasanton, and colleagues analyzed data from nearly 1.1 million adults aged 50 to 75 years across 22 medical centers from 2000 to 2019 to examine screening and CRC-related outcomes. Programmatic screening was introduced in 2006 to 2008, with annual ascertainment of up-to-date status by colonoscopy, sigmoidoscopy, or fecal immunochemical testing (FIT); for those not up-to-date, mailed outreach was performed using FIT.

The researchers found that after introduction of systematic FIT-based screening, up-to-date screening status more than doubled, from 37.4 to 79.8 percent between 2000 and 2019, with similar patterns seen across all racial and ethnic groups. CRC incidence rates increased in these groups from 109.1 to 126.4 cases per 100,000 in 2002, concordant with increased screening prevalence. Rates then peaked during 2008 to 2010, consistent with increased early detection of cancers, and then decreased gradually, in accordance with cancer prevention resulting from polyp detection and removal, to 66.3, 78.3, 78.4, and 87.1 cases per 100,000 in Asian, Hispanic, White, and Black members, respectively, in 2019. From 2002 to 2019, there was a decrease noted in CRC-related deaths to 15.3, 20.7, 21.9, and 23.5 per 100,000 in Asian, White, Hispanic, and Black members, respectively.

"Ten years ago, there were big gaps in cancer risk and death, especially among our Black patients," Corley said in a statement. "Now, those differences are nearly gone."

More Information

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-04-26 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords